Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1102 | 9807 | 34.4 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
1102 | 2 | PACLITAXEL//TAXANES//EPOTHILONES | 9807 |
2951 | 1 | TAXACEAE//TAXOIDS//TAXUS CUSPIDATA | 2104 |
2966 | 1 | METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL | 2101 |
6731 | 1 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//GOSHAJINKIGAN//CIPN | 1450 |
7277 | 1 | PACLITAXEL//CREMOPHOR EL//DOCETAXEL | 1386 |
10628 | 1 | EPOTHILONES//IXABEPILONE//PATUPILONE | 1047 |
14245 | 1 | VINFLUNINE//VINCA ALKALOIDS//VINCRISTINE | 782 |
15859 | 1 | TAXOL//PACLITAXEL//BCL 2 PHOSPHORYLATION | 688 |
26652 | 1 | NOSCAPINE//NOSCAPINOIDS//AMINO NOSCAPINE | 249 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PACLITAXEL | authKW | 874065 | 13% | 21% | 1310 |
2 | TAXANES | authKW | 571998 | 5% | 40% | 461 |
3 | EPOTHILONES | authKW | 553048 | 2% | 78% | 229 |
4 | TAXOL | authKW | 519320 | 5% | 36% | 463 |
5 | METASTATIC BREAST CANCER | authKW | 496650 | 5% | 32% | 503 |
6 | TAXACEAE | authKW | 400241 | 2% | 79% | 162 |
7 | TAXOIDS | authKW | 366977 | 2% | 72% | 164 |
8 | DOCETAXEL | authKW | 338341 | 6% | 18% | 621 |
9 | IXABEPILONE | authKW | 248162 | 1% | 77% | 103 |
10 | VINORELBINE | authKW | 230335 | 3% | 28% | 264 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 73615 | 45% | 1% | 4414 |
2 | Pharmacology & Pharmacy | 10234 | 21% | 0% | 2031 |
3 | Chemistry, Medicinal | 5232 | 8% | 0% | 738 |
4 | Chemistry, Organic | 1801 | 8% | 0% | 758 |
5 | Biochemical Research Methods | 357 | 3% | 0% | 295 |
6 | Chemistry, Analytical | 320 | 4% | 0% | 397 |
7 | Plant Sciences | 318 | 4% | 0% | 410 |
8 | Integrative & Complementary Medicine | 265 | 1% | 0% | 76 |
9 | Biotechnology & Applied Microbiology | 156 | 3% | 0% | 322 |
10 | Chemistry, Multidisciplinary | 142 | 6% | 0% | 573 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PL BIOORGAN CHEMAOBA KU | 42855 | 0% | 42% | 33 |
2 | MED ONCOL | 34282 | 7% | 2% | 725 |
3 | ANTINEOPLAST PHARMACOL | 31097 | 0% | 50% | 20 |
4 | UNIT NEUROONCOL | 28994 | 0% | 55% | 17 |
5 | NEW MAT BIOL | 21782 | 0% | 100% | 7 |
6 | NO ALBERTA BREAST CANC PROGRAM | 21782 | 0% | 100% | 7 |
7 | BIOMED MASS SPE OMETRY UNIT | 20552 | 0% | 37% | 18 |
8 | NEUROSCI BIOMED TECHNOL | 16024 | 0% | 15% | 35 |
9 | BREAST CANC MED SERV | 15812 | 0% | 18% | 29 |
10 | PRECLIN PHARMACOL CORE IL | 15313 | 0% | 62% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 43844 | 3% | 4% | 323 |
2 | SEMINARS IN ONCOLOGY | 39151 | 3% | 5% | 257 |
3 | ANTI-CANCER DRUGS | 22673 | 2% | 5% | 155 |
4 | ANNALS OF ONCOLOGY | 17827 | 2% | 3% | 219 |
5 | CLINICAL BREAST CANCER | 12170 | 1% | 7% | 55 |
6 | JOURNAL OF CLINICAL ONCOLOGY | 11918 | 3% | 2% | 253 |
7 | INVESTIGATIONAL NEW DRUGS | 8663 | 1% | 3% | 85 |
8 | BREAST CANCER RESEARCH AND TREATMENT | 8314 | 1% | 2% | 141 |
9 | ONCOLOGY | 6834 | 1% | 2% | 94 |
10 | EUROPEAN JOURNAL OF CANCER | 6060 | 1% | 1% | 142 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PACLITAXEL | 874065 | 13% | 21% | 1310 | Search PACLITAXEL | Search PACLITAXEL |
2 | TAXANES | 571998 | 5% | 40% | 461 | Search TAXANES | Search TAXANES |
3 | EPOTHILONES | 553048 | 2% | 78% | 229 | Search EPOTHILONES | Search EPOTHILONES |
4 | TAXOL | 519320 | 5% | 36% | 463 | Search TAXOL | Search TAXOL |
5 | METASTATIC BREAST CANCER | 496650 | 5% | 32% | 503 | Search METASTATIC+BREAST+CANCER | Search METASTATIC+BREAST+CANCER |
6 | TAXACEAE | 400241 | 2% | 79% | 162 | Search TAXACEAE | Search TAXACEAE |
7 | TAXOIDS | 366977 | 2% | 72% | 164 | Search TAXOIDS | Search TAXOIDS |
8 | DOCETAXEL | 338341 | 6% | 18% | 621 | Search DOCETAXEL | Search DOCETAXEL |
9 | IXABEPILONE | 248162 | 1% | 77% | 103 | Search IXABEPILONE | Search IXABEPILONE |
10 | VINORELBINE | 230335 | 3% | 28% | 264 | Search VINORELBINE | Search VINORELBINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WANG, YF , SHI, QW , DONG, M , KIYOTA, H , GU, YC , CONG, B , (2011) NATURAL TAXANES: DEVELOPMENTS SINCE 1828.CHEMICAL REVIEWS. VOL. 111. ISSUE 12. P. 7652-7709 | 341 | 87% | 43 |
2 | FEHRENBACHER, JC , (2015) CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY.MOLECULAR AND CELL BIOLOGY OF PAIN. VOL. 131. ISSUE . P. 471 -508 | 184 | 69% | 7 |
3 | HERSHMAN, DL , LACCHETTI, C , DWORKIN, RH , SMITH, EML , BLEEKER, J , CAVALETTI, G , CHAUHAN, C , GAVIN, P , LAVINO, A , LUSTBERG, MB , ET AL (2014) PREVENTION AND MANAGEMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN SURVIVORS OF ADULT CANCERS: AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 32. ISSUE 18. P. 1941 -+ | 75 | 88% | 107 |
4 | PARMAR, VS , JHA, A , BISHT, KS , TANEJA, P , SINGH, SK , KUMAR, A , POONAM , JAIN, R , OLSEN, CE , (1999) CONSTITUENTS OF THE YEW TREES.PHYTOCHEMISTRY. VOL. 50. ISSUE 8. P. 1267 -1304 | 139 | 96% | 127 |
5 | PARK, SB , GOLDSTEIN, D , KRISHNAN, AV , LIN, CSY , FRIEDLANDER, ML , CASSIDY, J , KOLTZENBURG, M , KIERNAN, MC , (2013) CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY: A CRITICAL ANALYSIS.CA-A CANCER JOURNAL FOR CLINICIANS. VOL. 63. ISSUE 6. P. 419-437 | 121 | 61% | 55 |
6 | HAN, YQ , SMITH, MT , (2013) PATHOBIOLOGY OF CANCER CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN).FRONTIERS IN PHARMACOLOGY. VOL. 4. ISSUE . P. - | 120 | 70% | 25 |
7 | ALTMANN, KH , PFEIFFER, B , ARSENIYADIS, S , PRATT, BA , NICOLAOU, KC , (2007) THE CHEMISTRY AND BIOLOGY OF EPOTHILONES - THE WHEEL KEEPS TURNING.CHEMMEDCHEM. VOL. 2. ISSUE 4. P. 396 -423 | 119 | 83% | 65 |
8 | ARGYRIOU, AA , BRUNA, J , MARMIROLI, P , CAVALETTI, G , (2012) CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY (CIPN): AN UPDATE.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 82. ISSUE 1. P. 51 -77 | 124 | 57% | 95 |
9 | AVAN, A , POSTMA, TJ , CERESA, C , AVAN, A , CAVALETTI, G , GIOVANNETTI, E , PETERS, GJ , (2015) PLATINUM-INDUCED NEUROTOXICITY AND PREVENTIVE STRATEGIES: PAST, PRESENT, AND FUTURE.ONCOLOGIST. VOL. 20. ISSUE 4. P. 411 -432 | 109 | 58% | 27 |
10 | KAISER, S , MULLER, JJ , FROEHLICH, PE , GNOATTO, SCB , BERGOLD, AM , (2013) FROM BACTERIA TO ANTINEOPLASTIC: EPOTHILONES A SUCCESSFUL HISTORY.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 7. P. 1057-1068 | 103 | 88% | 6 |
Classes with closest relation at Level 2 |